# The Chemo-Gut Probiotic Trial for Cancer Survivors

> **NCT06088940** · NA · UNKNOWN · sponsor: **University of Calgary** · enrollment: 66 (estimated)

## Conditions studied

- Cancer
- Psychosocial Problem
- Gastrointestinal Dysfunction

## Interventions

- **DIETARY_SUPPLEMENT:** Multistrain Probiotic
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06088940
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-10
- **Primary completion:** 2024-11-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06088940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06088940, "The Chemo-Gut Probiotic Trial for Cancer Survivors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06088940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
